It would be devastating if women learned how to stop breast cancer before it started.
More than 200,000 women in the U.S. would not need to purchase expensive treatment and drugs each year. Billions of dollars in profits would be lost overnight.
For example, tens of thousands of women would have no need to purchase Taxol, Tamoxifen, Arimidex, Herceptin or other breast cancer drugs. Oncologists would lose millions of dollars in drug company commissions from these prescriptions and even more dollars each year from patient insurance and co-pays.
If women stopped developing invasive breast cancer, an untold number of jobs would soon be lost within medical centers, radiology clinics and pharmaceutical companies as the demand for breast cancer drugs and services ground to a halt. Worse, new construction for expanded breast surgery and reconstruction clinics would be cancelled, most mammography centers might need to close and research dollars for new breast cancer genetic tests, vaccines and find- the- cure drugs would dry up. Susan G Komen and a good portion of the American Cancer Society would shut down operations.
Also, agency chiefs and middle managers in our national cancer agencies, (National Cancer Institute, Centers for Disease Control and Food and Drug Administration) would no longer switch between higher paying government and private sector cancer jobs as much. This current revolving-door culture means that government reports sometimes appear to support Big Pharma, or the radiation industry, instead of keeping women informed on how to stop breast cancer before it starts.
Just take a look at a recent government Vitamin D3 report that says women should stop taking Vitamin D3 supplements.
What a silly idea!!!
What should we make of this document by the Preventative Services Task Force that actually ignores dozens of recent studies supporting higher levels of D3 and instead tells us that vitamin D3 is fairly useless when it comes to protecting bones, or helping prevent a breast cancer diagnosis??!!
I won’t comment on the individuals selected to serve on this current national Task Force, the group that issued this out -of -date report. It is more important to focus on the research its members were asked to review.
You know the saying.. junk in.. junk out. Well the Task Force was asked to review or comment upon two older studies where women took very low doses of vitamin D3 each day (400 IU).
Surprise!! These research studies showed that taking only 400 IUs (international units) of D3 supplements daily, had little to no effect on improved bone density. These same research studies also found that these low levels of vitamin D3 supplementation did not have any effect on breast cancer prevention.
Using these two studies as their information base, the Task Force’s report says taking Vitamin D3 supplements is useless.
I would encourage the Task Force to erase their current report and try reviewing at least five of the most recent, most comprehensive studies of what happens to breast, prostate and colon cancer rates when a person uses safe tanning and adequate vitamin D3 supplements (2,000-5,000 IUs/day) in order to maintains 50-80 ng/ml of vitamin D3 in their blood serum.
PRESTO… cancer prevention happens!!!
Read these studies yourself & don’t miss seeing the video by Dr Cedric Garland of the Moores Cancer Center in San Diego, as he describes the biological mechanism that happens as vitamin D3 blocks tumor growth.
Garland’s DINOMIT theory of cancer shows how breast, prostate and colon cells, when given enough vitamin D3, become a coordinated safety net, protecting each specific organ from developing cancerous tumors.
If you want a book on the subject, try Dr Michael Holick’s 2010 book, The Vitamin D3 Solution. Visit www.bustingbreastcancer.org to see these and other resources.
Women (and those who love us), it turns out, are the only group within the U.S. culture today with the self interest and the power to stop breast cancer before it starts. So women must take charge of boosting their individual D3 blood serum levels.
Five Recent Cancer/Vitamin D3 Studies:
Fedirko V, Torres-Mej¡a G, Ortega-Olvera C, Biessy C, Angeles-Llerenas A, Lazcano-Ponce E, et al. Serum 25-hydroxyvitamin D and risk of breast cancer: results of a large population-based case-control study in Mexican women. Cancer Causes Control. ;23:1149-62, 2012.
Garland CF, French CB, Baggerly LL, Heaney RP. Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Research; 31:617-22.2011.
Garland, C , et al, Vitamin D for Cancer Prevention: Global Perspective Annals of Epidemiology Vol. 19, Issue 7, Pages 468-483 July 2009.
Goodwin, P J, et al, Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer, Journal of Clinical Oncology, , vol 27 no 23 3757-3763, Aug 10, 2009.
Marshall DE, Savage SJ, Garrett-Mayer E, Keane TE, Hollis BW, Host RL, et al., Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab, jc.2012-1451 April 16, 2012.